Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/11/2001 | US20010029040 Agent for gene therapy of dilated cardomyopathy |
10/11/2001 | US20010029034 Hemostasis system-related disorders treatment |
10/11/2001 | US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters |
10/11/2001 | US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof |
10/11/2001 | US20010029025 Method of identifying proteins |
10/11/2001 | US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein |
10/11/2001 | US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
10/11/2001 | US20010029018 Deparaffinizing tissue sample, rehydrating, heating and homogenizing in chaotropic agent (guanidine thiocyanate), recovering RNA and converting to cDNA by reverse tran-scription, then polymerase chain reaction with fluorescent dye |
10/11/2001 | US20010029014 Methods and kits for identifying elite event GAT-ZM1 in biological samples |
10/11/2001 | EP1145448A3 Radio communications unit |
10/11/2001 | EP1144679A3 Capillary array-based sample screening |
10/11/2001 | EP1144656A3 Method for the isolation of ccc plasmid dna |
10/11/2001 | EP1144591A3 Low oxygen culturing of cells |
10/11/2001 | EP1144447A3 Tuberculosis diagnostic test |
10/11/2001 | DE19953478A1 Genetically modified yeast lacking endogenous potassium transport activity, useful for identifying e.g. antiarrhythmic agents, includes a functional human potassium channel |
10/11/2001 | DE10017057A1 New ribosomal L1 protein gene from coryneform bacteria, useful, when downregulated, for increasing fermentative production of amino acids |
10/11/2001 | DE10015458A1 Preparing transgenic monocotyledonous plants for producing cereals, comprises timing the stages for optimal proliferative and regenerative capacity without use of marker DNA |
10/11/2001 | DE10015448A1 Detection and quantification of binding between affinity molecules useful in screening for drugs, does not require removal of reaction solution prior to measurement |
10/11/2001 | DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides |
10/11/2001 | DE10013204A1 DNA-Sequenz und Verfahren zur in vivo-Markierung und Analyse von DNA/Chromatin in Zellen DNA sequence and methods for in vivo labeling and analysis of DNA / chromatin in cells |
10/11/2001 | DE10012604A1 Transgenic animal expressing indicator gene specifically in the nervous system, useful for developing and testing therapeutic and diagnostic methods and agents |
10/11/2001 | CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
10/11/2001 | CA2408904A1 Compositions and methods of using hiv vpr |
10/11/2001 | CA2405549A1 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcription coupled repair genes |
10/11/2001 | CA2405515A1 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w |
10/11/2001 | CA2405473A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
10/11/2001 | CA2405332A1 Fluorescence assay for gamma-secretase activity and inhibitors |
10/11/2001 | CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions |
10/11/2001 | CA2405147A1 Human serine racemase |
10/11/2001 | CA2405063A1 Subtilisin variants |
10/11/2001 | CA2405035A1 Improved method for the production of bacterial toxins |
10/11/2001 | CA2404978A1 Methods, compositions and kits for the detection and monitoring of breast cancer |
10/11/2001 | CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
10/11/2001 | CA2404961A1 Method for producing authentic cytokines in plants |
10/11/2001 | CA2404896A1 Human ion channel protein and polynucleotides encoding the same |
10/11/2001 | CA2404890A1 Rna sequence-specific mediators of rna interference |
10/11/2001 | CA2404869A1 Peptides mimicking the biological activity of steroid hormones and their uses |
10/11/2001 | CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
10/11/2001 | CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits |
10/11/2001 | CA2404568A1 Epigenetic sequences for esophageal adenocarcinoma |
10/11/2001 | CA2404555A1 Novel nucleic acids and polypeptides |
10/11/2001 | CA2404541A1 G-protein coupled receptors and nucleic acids encoding same |
10/11/2001 | CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same |
10/11/2001 | CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same |
10/11/2001 | CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
10/11/2001 | CA2404498A1 Sigma binding region of rna polymerase and uses thereof |
10/11/2001 | CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
10/11/2001 | CA2404479A1 Hybrid cytokine of il-7 and .beta.-chain of hepatocyte growth factor |
10/11/2001 | CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells |
10/11/2001 | CA2404291A1 Butylnitrone containing compositons for inhibition of cancer development |
10/11/2001 | CA2404257A1 Novel protein, dna thereof and process for producing the same |
10/11/2001 | CA2404074A1 Human polynucleotides, polypeptides, and antibodies |
10/11/2001 | CA2403998A1 Mucin-1 specific binding members and methods of use thereof |
10/11/2001 | CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy |
10/11/2001 | CA2403779A1 Detection of nerve damage using marker scip |
10/11/2001 | CA2403303A1 Method of identifying ginko biloba in a plant extract by gene profiling |
10/11/2001 | CA2402857A1 Atrsp gene promoters |
10/11/2001 | CA2402525A1 Compositions and methods for detecting and quantifying gene expression |
10/11/2001 | CA2402452A1 Improvements to ribosome display |
10/11/2001 | CA2401948A1 Cd20/ige-receptor like molecules and uses thereof |
10/11/2001 | CA2401158A1 .beta. 2 adrenergic polymorphism detection |
10/11/2001 | CA2399934A1 Methods involving induced dimerisation by cellular components |
10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
10/11/2001 | CA2393117A1 Incrementally truncated nucleic acids and methods of making same |
10/11/2001 | CA2388673A1 Protein having activity as an angiogenesis modulator |
10/11/2001 | CA2376710A1 A computer based method for identifying conserved invariant peptide motifs |
10/11/2001 | CA2341786A1 Truncated reelin protein and dna encoding the same |
10/10/2001 | EP1143016A2 Optical and electrical methods and apparatus for molecule detection |
10/10/2001 | EP1143015A2 Optical and electrical methods and apparatus for molecule detection |
10/10/2001 | EP1143014A2 Optical and electrical methods and apparatus for molecule detection |
10/10/2001 | EP1143013A1 Methods and compositions for screening Icrac modulators |
10/10/2001 | EP1143011A2 A method of detecting biologically active substances |
10/10/2001 | EP1143009A1 Process for producing polypeptide in cell-free protein synthesis system |
10/10/2001 | EP1143006A2 Vectors/DNA-sequences from human combinatorial antibody libraries |
10/10/2001 | EP1143005A1 Human secretory phospholipase a 2? |
10/10/2001 | EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
10/10/2001 | EP1143003A2 Nucleic acid sequences coding for the rplk gene and a process for preparing L-amino acids |
10/10/2001 | EP1143002A1 Sodium/proton countertransporter gene |
10/10/2001 | EP1143001A1 Novel interferon-alpha |
10/10/2001 | EP1143000A1 Screening method |
10/10/2001 | EP1142999A1 Novel protein and dna thereof |
10/10/2001 | EP1142998A1 Method of breeding yeast |
10/10/2001 | EP1142997A1 Novel rhodococcus, rhodococcus-origin nitrilase gene, nitrilehydratase gene and amidase gene and process for producing carboxylic acids by using the same |
10/10/2001 | EP1142996A1 Monoclonal antibody against apolipoprotein a-i |
10/10/2001 | EP1142995A1 Antiuracil monoclonal antibody |
10/10/2001 | EP1142994A1 Thermostable creatine amidinohydrolase and process for producing the same |
10/10/2001 | EP1142993A1 Novel serine protease bssp5 |
10/10/2001 | EP1142992A1 Polypeptides |
10/10/2001 | EP1142990A1 Process for producing transglutaminase |
10/10/2001 | EP1142989A2 Chondrocyte cell-lines |
10/10/2001 | EP1142910A1 Inhibitors for the formation of soluble human CD23 |
10/10/2001 | EP1142909A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein |
10/10/2001 | EP1142908A1 Process for producing activated protein |
10/10/2001 | EP1142907A1 THE POLYPEPTIDE DREAM, USED AS Ca2+ IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR |
10/10/2001 | EP1142591A1 Gene carriers |
10/10/2001 | EP1142580A1 Use of peptide |
10/10/2001 | EP1142579A2 Bone resorption inhibitors |
10/10/2001 | EP1142484A2 Isolation of lactoferrin from milk |
10/10/2001 | EP1142473A1 Method of acquiring immunological tolerance |
10/10/2001 | EP1142472A1 Bacterial cell component-unresponsive model mouse |